Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Identify compelling low-cost index funds for retirement by evaluating tracking error, fees, and diversification. Build a lineup aligned with long-term goals.
27,243 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Bank earnings just dropped fresh clues about how Americans are spending, borrowing, and saving. This deep dive breaks...
Energy markets are shifting as AI data centers demand power and geopolitical risk raises prices. Here are three no-br...
In today’s Morning Minute, Circle earnings take center stage as crypto markets rally. Stablecoins anchor liquidity wh...
Headwinds have pressured Vornado, but two strategic catalysts could unlock meaningful upside. This guide breaks down ...
A bold public project turns a mountain of documents into a temporary library in New York. This article breaks down th...
If you’re building a decade-long plan, these energy stocks worth holding offer durable cash flow, solid dividends, an...
Oil prices rise and equity futures turn lower as tensions with Iran fresh escalate. Investors brace for higher energy...
Sandisk stock has surged dramatically this year, but a rally this strong begs tough questions. This guide breaks down...
Politician Vance argues households are nominally richer by about $1,000, but economists say inflation has eaten into ...
An aviation mechanics graduate with offers in hand marks a bright spot in a tight labor market for aviation technicia...
The 2026 IPO boom is broadening beyond AI megadeals as mid-cap and overlooked sectors attract new capital. A busy sec...